Edward H Myles
CIK 1358219 · COO & CFO · last filed 2025-03-12
Edward H Myles is a COO & CFO who has filed 41 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for SRRK, was dated Mar 12, 2025. Across all open-market trades the lifetime net is −$16.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.08M
4
41
-$16.81M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRRK | COO & CFO | 205,552 | $44.18 | $9.08M | -$16.81M | 24 | 2025-03-12 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | COO & CFO | 98,659 | — | — | $0 | 12 | 2020-03-12 |
| Ocata Therapeutics, Inc. (OCAT) Delisted | COO & CFO | 0 | — | — | $0 | 1 | 2016-02-11 |
| PRESSURE BIOSCIENCES INC (PBIO) Delisted | Senior VP of Finance & CFO | — | — | — | $0 | 1 | 2008-09-29 |
Recent Filings
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-12 | SRRK | Mixed | −29,395 | -$3.53M | EDGAR |
| 2025-02-20 | SRRK | Sell (S) | −7,809 | -$287.6K | EDGAR |
| 2025-01-21 | SRRK | Sell (S) | −12,539 | -$554.2K | EDGAR |
| 2024-10-10 | SRRK | Mixed | — | -$925.8K | EDGAR |
| 2024-10-07 | SRRK | Mixed | −412,480 | -$8.33M | EDGAR |
| 2024-06-18 | SRRK | Sell (S) | −9,458 | -$85.0K | EDGAR |
| 2024-02-21 | SRRK | Sell (S) | −4,744 | -$74.7K | EDGAR |
| 2024-02-13 | SRRK | Grant (A) | +53,570 | $0 | EDGAR |
| 2024-01-18 | SRRK | Sell (S) | −6,634 | -$105.7K | EDGAR |
| 2023-12-29 | SRRK | Mixed | — | -$174.1K | EDGAR |